Walleye Trading’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-75,300
Closed -$6.4M 5220
2020
Q3
$6.4M Buy
75,300
+68,600
+1,024% +$3.47M 0.03% 456
2020
Q2
$237K Buy
+6,700
New +$196K ﹤0.01% 2942
2019
Q4
Sell
-13,200
Closed -$175K 4782
2019
Q3
$175K Sell
13,200
-33,700
-72% -$495K ﹤0.01% 3025
2019
Q2
$651K Buy
46,900
+27,500
+142% +$414K 0.01% 1977
2019
Q1
$373K Buy
19,400
+19,300
+19,300% +$311K ﹤0.01% 2507
2018
Q4
$1K Sell
100
-3,300
-97% -$65.5K ﹤0.01% 4531
2018
Q3
$71K Sell
3,400
-54,600
-94% -$1.29M ﹤0.01% 4397
2018
Q2
$1.37M Sell
58,000
-8,200
-12% -$165K 0.01% 1745
2018
Q1
$967K Buy
+66,200
New +$1.08M 0.01% 1961
2017
Q4
Sell
-9,200
Closed -$129 4775
2017
Q3
$129 Buy
9,200
+1,700
+23% +$16.9K ﹤0.01% 3500
2017
Q2
$66 Buy
+7,500
New +$52.7K ﹤0.01% 3765

Walleye Trading's IMMU Position: Q4 2020 in Review

Walleye Trading sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 10,449 shares — an estimated $888K sold.

Walleye Trading first reported a position in IMMU in Q2 2015 and held it in 5 quarters. The position peaked at $888K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Walleye Trading reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Walleye Trading sold 10,449 Immunomedics Inc shares in Q4 2020, an estimated $888K.
  • Walleye Trading first reported a position in Immunomedics Inc in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's Immunomedics Inc position peaked at $888K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.